Risk Stratification Guides Early Treatment in Smoldering Myeloma: Peter Voorhees, MD
Peter Voorhees, MD, emphasizes the importance of carefully determined early regimens for smoldering myeloma and involving patients in treatment decisions.
Daratumumab Offers Hope for Delaying Progression to Active MM: Peter Voorhees, MD
Peter Voorhees, MD, explains how daratumumab and hyaluronidase-fihj show superior efficacy in delaying progression of MM compared with active monitoring.
